Usefulness of longitudinal assessment of AFP in DAA cured HCV cirrhotic patients to predict the developmente of HCC

Sangiovanni, A.; Alimenti, Eleonora; Gattai, Riccardo; Filomia, Roberto; Parente, Elisabetta; Valenti, Luca; Marzi, Luca; Pieri, Giulia; Borgia, Guglielmo; Gambato, Martina; Terreni, N.; Serio, Ilaria; Belli, Luca; Oliveri, Filippo; Maimone, S.; Torres, Maria Corinna Plaz; D’Ambrosio, Roberta; Iavarone, M.; Forzenigo, L.V.; Russo, Francesco; Rumi, Maria Grazia; Barone, M.; Raimondo, Giovanni; Giannini, Edoardo G.; Brunetto, M.R.; Villa, Erica; Silvestri, Annalisa De; Colombo, Massimo G.; Lampertico, Pietro

doi:10.1016/s0168-8278(22)01477-5

Journal of Hepatology

2022

DOI: 10.1016/s0168-8278(22)01477-5

|View full text |Cite

Usefulness of longitudinal assessment of AFP in DAA cured HCV cirrhotic patients to predict the developmente of HCC

A. Sangiovanni¹,

Eleonora Alimenti²,

Riccardo Gattai³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…За індексом Юдена значення АФП вище 8 нг/мл, виявлене у будь-який час, визначало найбільший точний поріг для прогнозування ГЦК, що відповідало 59,6% чутливості та 96,5% специфічності. Специфічність 99% була досягнута при значенні АФП >21 нг/мл, що відповідає чутливості 23,9% [24].…”

unclassified

Non-Alcoholic Fatty Liver Disease in Proceedings of Congress Easl – 2023

Pinsky

2023

Med. Sci. of Ukr.

View full text Add to dashboard Cite

Background. The significant increase in the prevalence of type 2 diabetes has led to an increase in the incidence of its hepatic manifestations, in particular non-alcoholic fatty liver disease. A complication of this disease is the asymptomatic progression of fibrosis, the development of liver cirrhosis and hepatocellular carcinoma. Aim. To analyze the results of studies on non-alcoholic fatty liver disease that were reviewed at the Congress of the European Association for the Study of the Liver (EASL - 2023). Materials and methods. Analysis of current data presented in the materials of the Congress of the European Association for the Study of the Liver (EASL - 2023) on the prevalence, pathogenesis and treatment of non-alcoholic fatty liver disease. Conclution. Non-alcoholic fatty liver disease and the new term metabolic associated steatohepatitis (MASH) are the hepatic manifestations of type 2 diabetes mellitus, the prevalence of which is rapidly increasing with the increasing incidence of uncontrolled hyperglycemia. The new term MASH, which replaced the diagnosis of NAFLD, emphasizes that the main etiopathogenetic factor in the development of this liver pathology is type 2 diabetes mellitus. The progression of liver fibrosis and the development of hepatocellular carcinoma in MASH can be caused not only by a high level of glycated hemoglobin, but also by multiple comorbid factors, in particular, autoimmune hepatitis, alcoholic and drug-induced liver damage, hemochromatosis, etc.

show abstract

unclassified

Non-Alcoholic Fatty Liver Disease in Proceedings of Congress Easl – 2023

Pinsky

2023

Med. Sci. of Ukr.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Usefulness of longitudinal assessment of AFP in DAA cured HCV cirrhotic patients to predict the developmente of HCC

Cited by 1 publication

References 0 publications

Non-Alcoholic Fatty Liver Disease in Proceedings of Congress Easl – 2023

Non-Alcoholic Fatty Liver Disease in Proceedings of Congress Easl – 2023

Contact Info

Product

Resources

About